Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Antonella, Barale"'
Autor:
Fabrizio Faggiano, Maicol Andrea Rossi, Tiziana Cena, Fulvia Milano, Antonella Barale, Quenya Ristagno, Virginia Silano
Publikováno v:
Vaccines, Vol 9, Iss 8, p 859 (2021)
An outbreak was described among the guests of a Long-Term Care Facility in the North of Italy. Among 23 guests, 20 of whom were fully vaccinated with BNT162b2 vaccine, the outbreak led to a final count of 11 positive guests, 9 of whom were vaccinated
Externí odkaz:
https://doaj.org/article/0fe098dcb6a74ef09c1bccb9e5f650b9
Autor:
Quenya Ristagno, Maicol Andrea Rossi, Tiziana Cena, Virginia Silano, Fabrizio Faggiano, Antonella Barale, Fulvia Milano
Publikováno v:
Vaccines
Vaccines, Vol 9, Iss 859, p 859 (2021)
Vaccines, Vol 9, Iss 859, p 859 (2021)
An outbreak was described among the guests of a Long-Term Care Facility in the North of Italy. Among 23 guests, 20 of whom were fully vaccinated with BNT162b2 vaccine, the outbreak led to a final count of 11 positive guests, 9 of whom were vaccinated
Autor:
Daniela, Alessi, Silvio, Borré, Antonella, Barale, Antonio, Isabella, Fulvia, Milano, Maicol Andrea, Rossi, Virginia, Silano, Nicola, Piu, Tiziana, Cena, Fabrizio, Faggiano, Stefano, Vantaggiato
Publikováno v:
Epidemiologia e prevenzione. 44(5-6 Suppl 2)
to avoid a new spread of the SARS-CoV-2 infection, the post lockdown period requires the implementation of effective strategies for the case finding and contact tracing. The presence of asymptomatic subjects in the population, that are responsible fo
Autor:
Alessandro Remo, Zanetti, Luisa, Romanò, Cristina, Giambi, Anna, Pavan, Vito, Carnelli, Guglielmino, Baitelli, Giancarlo, Malchiodi, Edgardo, Valerio, Antonella, Barale, Maria Anna, Marchisio, Domenico, Montù, Alberto Eugenio, Tozzi, Fortunato, D'Ancona, E, Pandolfi
Publikováno v:
The Lancet Infectious Diseases. 10:755-761
In 2000, hexavac and infanrix hexa were licensed in Europe for primary immunisation of children against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive infections caused by Haemophilus influenzae b. In 2005, hexavac was suspe
Publikováno v:
Evidence-Based Child Health: A Cochrane Review Journal. 2:965-986
Background Tetanus is an acute, often fatal, disease caused by an exotoxin produced by Clostridium tetani. It occurs in newborn infants born to mothers who do not have sufficient circulating antibodies to protect the infant passively, by transplacent
Publikováno v:
The Cochrane Library
Background Tetanus is an acute, often fatal, disease caused by an exotoxin produced by Clostridium tetani. It occurs in newborn infants born to mothers who do not have sufficient circulating antibodies to protect the infant passively, by transplacent
Autor:
Antonino Bella, Antonella Barale, Marta Ciofi Degli Atti, Maurizio Oddone, Elisabetta Madonna, Domenico Montù, Maria Rapicetta, Cristina Giambi, Maria Anna Marchisio, Salvatore Zito, Paola Chionne
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 8, Iss 1, p 100 (2008)
BMC Infectious Diseases, Vol 8, Iss 1, p 100 (2008)
Background In 2001, two hexavalent vaccines were licensed in Italy (Hexavac®, Infanrix Hexa®), and since 2002 were extensively used for primary immunization in the first year of life (at 3, 5, 11/12 months of age). In 2005, the market authorization
BACKGROUND: Tetanus is an acute, often fatal, disease caused by an exotoxin produced by Clostridium tetani. It occurs in newborn infants born to mothers who do not have sufficient circulating antibodies to protect the infant passively, by transplacen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a259c7b6d781ac441107318e0f8882
https://doi.org/10.1002/14651858.cd002959.pub2
https://doi.org/10.1002/14651858.cd002959.pub2
Autor:
Elena Telaro, Fabrizio Faggiano, Alessandro Liberati, Livia Candelise, Graziella Filippini, Vittorio De Micheli, Antonella Barale, Sabrina Bidoli, Roberto D'Amico, Marina Davoli, Vanna Pistotti, Marica Ferri, Liliana Coco
Publikováno v:
BMC News and views. 1
Autor:
Antonella Barale
Publikováno v:
Vaccine. 22:2044-2045
The Cochrane Vaccines Field (CVF) is a Cochrane Collaboration entity. The CVF was founded to facilitate the gathering of evidence on vaccines and their effects (ability to prevent the target disease, short and long term safety and efficiency) finalis